Tyler Brooks
CANDLE syndrome, or Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature, is a rare autoinflammatory disease that typically presents in the first year of a child's life. The syndrome is characterised by recurring fevers, skin lesions, lipodystrophy (fat loss), joint pain, and inflammation of organs. The cause of CANDLE syndrome is a mutation in the PSMB8 gene or mutations in other closely related genes, leading to a buildup of protein waste products, cellular stress, and chronic inflammation.
| Characteristics | Values |
|---|---|
| Cause | Mutation in the PSMB8 gene or mutations in other closely related genes |
| Type | Autoinflammatory disease (AID) |
| Symptoms | Recurrent fever, skin lesions, lipodystrophy, manifestations of multisystem inflammation, joint pain, developmental delays, swollen eyelids, muscle contractures and stiffness, muscle wasting, abnormal fat loss, rashes, ulcers, internal inflammatory responses, anemia, low height and weight |
| Diagnosis | Clinical exam, blood tests, imaging, biopsy of skin lesions, genetic testing |
| Treatment | Corticosteroids, methotrexate, baricitinib, JAK inhibitors, physical therapy |
Explore related products
What You'll Learn
Mutations in the PSMB8 gene
CANDLE syndrome, or Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated temperature syndrome, is a rare autoinflammatory disease that usually forms in a child's first year of life. The syndrome is characterised by recurrent fever, skin lesions, lipodystrophy, and manifestations of multisystem inflammation.
The current known cause of the syndrome is a mutation in the PSMB8 gene or mutations in other closely related genes. The PSMB8 gene provides instructions for making one part (subunit) of cell structures called immunoproteasomes. Mutations in the PSMB8 gene cause autoinflammation and lipodystrophy in humans. The mutated gene results in proteins not being degraded and oxidative proteins building up in cellular tissues, eventually leading to apoptosis, especially in muscle and fat cells.
One specific mutation in the PSMB8 gene has been identified in people with CANDLE syndrome, which replaces the amino acid cysteine with a signal to stop protein production prematurely (written as Cys135Ter or C135X). Each of these mutations greatly reduces protein production from the PSMB8 gene. It is unclear how mutations in this gene lead to the overlapping but distinct patterns of signs and symptoms in Nakajo-Nishimura syndrome, JMP syndrome, and CANDLE syndrome. Researchers speculate that mutations in different areas of the gene may have different effects on protein function.
Another mutation in the PSMB8 gene changes a single protein building block (amino acid) in the protein produced from the PSMB8 gene, replacing the amino acid glycine with the amino acid valine at protein position 201 (written as Gly201Val or G201V). This mutation has been found to cause Nakajo-Nishimura syndrome, a condition that has been described only in the Japanese population. This mutation also greatly reduces the production of this protein, impairing the normal assembly of immunoproteasomes and causing the immune system to malfunction.
A study conducted by Brehm et al. in November 2015 discovered additional mutations that can cause CANDLE syndrome, including PSMA3 (encodes α7), PSMB4 (encodes β7), PSMB9 (encodes β1i), and the proteasome maturation protein (POMP).
A Whiff of Luxury: 10-Ounce Candle Experience
You may want to see also
Explore related products
Malfunction of the immunoproteasome complex
CANDLE syndrome, or Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated temperature syndrome, is a rare autoinflammatory disorder typically diagnosed in infants. It is characterised by recurring fevers, skin lesions, rashes, ulcers, joint pain, and inflammation of organs such as the liver or intestine. The syndrome can also cause fat loss, chronic anemia, and low height and weight.
The syndrome is caused by a mutation in the PSMB8 gene or mutations in other closely related genes. The PSMB8 gene encodes the β5i catalytic subunit of the immunoproteasome. When this gene is mutated, proteins are not broken down properly, leading to a buildup of waste proteins in the cell, a condition known as poly-ubiquitinization. This accumulation of waste proteins causes cellular stress and triggers the production of type 1 interferons (IFNs).
The immunoproteasome complex is responsible for removing damaged cell proteins. In individuals with CANDLE syndrome, the mutated proteasome-immunoproteasome system is unable to remove all the waste proteins, leading to a vicious cycle of inflammation. The high levels of secreted type 1 IFNs recruit inflammatory cells that cause tissue damage. This results in a continuous state of inflammation with exacerbations, characteristic of CANDLE syndrome.
The malfunction of the immunoproteasome complex due to mutations in the PSMB8 gene and other related genes is a key factor in the development of CANDLE syndrome. This genetic disorder leads to a buildup of waste proteins, cellular stress, and increased inflammation, causing the various symptoms associated with the syndrome.
The Secret to Smooth Soy Candle Tops
You may want to see also
Explore related products
Autoinflammatory disorder
CANDLE syndrome, or Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature, is a rare autoinflammatory disorder. It is characterised by recurring fevers, skin lesions, lipodystrophy, and manifestations of multisystem inflammation. The syndrome is typically diagnosed among infants and children.
The accumulation of waste proteins and the increased production of interferons create a vicious cycle of inflammation in the body. The interferons attract inflammatory cells, including neutrophils and myeloid cells, which contribute to the skin lesions observed in CANDLE syndrome. The high levels of interferons also lead to a continuous state of inflammation with exacerbations, causing symptoms such as joint pain, muscle contractures, and organ inflammation.
The inheritance pattern of CANDLE syndrome can be autosomal recessive or in the form of a de novo mutation. Genetic testing is typically required to confirm a diagnosis of CANDLE syndrome, although it can sometimes be inconclusive. Blood tests, imaging, and skin lesion biopsies may also aid in the diagnosis. Early diagnosis and treatment are crucial as the risks associated with leaving CANDLE syndrome untreated are high.
Gel Candles: Eco-Friendly or Not?
You may want to see also
Explore related products
Skin lesions
CANDLE syndrome, an acronym for Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated temperature, is a rare autoinflammatory disease that forms in a child's first year of life. It is characterised by recurrent fever, skin lesions, and multisystemic inflammatory manifestations.
The skin lesions are caused by a mutation in the PSMB8 gene or mutations in other closely related genes. The mutated gene results in proteins not being degraded and oxidative proteins building up in cellular tissues, eventually leading to apoptosis, especially in muscle and fat cells. The accumulation of poly-ubiquitinized proteins causes further cellular stress and more type 1 interferon production, thus feeding a vicious cycle of inflammation.
Type 1 interferons (IFNs) are recognised by their receptor, with activation of the JAK/STAT pathway and subsequent dimerization of STAT proteins. The STAT dimers enter the nucleus and stimulate transcription of type 1 IFNs. JAK/STAT activation produces reactive oxygen and nitrogen species that are damaging to cell proteins. These damaged proteins, along with others generated by cell catabolism, are removed by the proteasome and the immunoproteasome. However, in CANDLE syndrome, the proteasome system does not work properly, and waste proteins accumulate in the cell, causing cellular stress and increased type 1 IFN production.
The high levels of secreted type 1 IFNs recruit inflammatory cells that cause tissue damage, leading to the development of skin lesions. The IFN signature is very strong in CANDLE syndrome, and patients have been shown to respond well to treatment with JAK inhibitors.
Essential Oil Drops for 4-oz Candles: How Much?
You may want to see also
Explore related products
Lipodystrophy
CANDLE syndrome, an acronym for Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature, is a rare autoinflammatory disorder. It is characterised by recurring fevers, skin lesions, progressive lipodystrophy, periorbital swelling, and failure to thrive. Lipodystrophy, or fat loss, is one of the most distinctive symptoms of CANDLE syndrome. This fat loss typically occurs in the face, neck, chest, arms, and belly, giving patients a general appearance of consumption, resembling a burnt-out candle.
The diagnosis of CANDLE syndrome typically involves a clinical examination, blood tests, imaging, and skin lesion biopsies. Genetic testing is often required to confirm the presence of mutations in the PSMB8 gene or related genes. Early diagnosis and intervention are crucial, as the risks associated with leaving CANDLE syndrome untreated are high. Treatments such as corticosteroids and methotrexate are commonly used to manage inflammation, and baricitinib, a drug approved for rheumatoid arthritis, has shown promising results in reducing symptoms and improving growth in patients with CANDLE syndrome.
CANDLE syndrome is a rare condition, with approximately 30 cases reported in the scientific literature as of 2015 and 60 known cases worldwide according to the Autoinflammatory Alliance. It typically presents within the first year of life, and early-onset fevers are a characteristic feature. The prognosis and survival rate for CANDLE syndrome are unclear due to its rarity and recent discovery. However, multi-organ inflammation is the most serious and life-threatening complication associated with the syndrome.
While the most common cause of CANDLE syndrome is mutations in the PSMB8 gene, additional mutations have been identified in genes encoding both immunoproteasome and constitutive proteasome subunits, including PSMB4, PSMA3, and PSMB9. These mutations contribute to the overall dysfunction of the proteasome-immunoproteasome system, leading to continuous inflammation and cellular stress. The inheritance pattern of CANDLE syndrome can be autosomal recessive or the result of a de novo mutation.
Candle Trading: Cohen's Method
You may want to see also
Frequently asked questions
CANDLE syndrome is a rare autoinflammatory disease that forms in a child's first year of life. It is characterised by recurring fevers, skin lesions, lipodystrophy, and manifestations of multisystem inflammation.
CANDLE syndrome is caused by a mutation in the PSMB8 gene or mutations in other closely related genes. The mutated gene results in proteins not being degraded and oxidative proteins building up in cellular tissues, eventually leading to apoptosis, especially in muscle and fat cells.
The symptoms of CANDLE syndrome include skin lesions, swollen eyelids, progressive fat loss, muscle contractures, stiffness, joint pain, and inflammation of organs like the liver or intestine.
Doctors usually diagnose CANDLE syndrome through a clinical exam. Blood tests, imaging, and biopsy of skin lesions may also aid in the diagnosis. Genetic testing can confirm the diagnosis.
